Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-035547
Filing Date
2019-06-07
Accepted
2019-06-07 16:30:39
Documents
2
Period of Report
2019-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1560
2 EX-24 DOCUMENT attachment1.htm EX-24 2139
  Complete submission text file 0001209191-19-035547.txt   5243
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Issuer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MEDIVATION, INC. 201 SPEAR ST., 3RD FLOOR SAN FRANCISCO CA 94105
Business Address
Cohen Cheryl (Reporting) CIK: 0001529371 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37507 | Film No.: 19886063